Neuropathic pain: Rewisca is indicated for the treatment of neuropathic pain which includes diabetic peripheral neuropathy and post-herpetic neuralgia in adults.
Epilepsy: Rewisca is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Generalised Anxiety Disorder: Rewisca is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Fibromyalgia: Rewisca is indicated for the management of fibromyalgia.